The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Hepatitis C: the clinical spectrum of disease.
Open accessAbstract
Hepatitis C virus (HCV) accounts for approximately 20% of cases of acute hepatitis, 70% of chronic hepatitis, and 30% of end-stage liver disease in the United States. The acute infection has an incubation period of 7 weeks (range, 4-20 weeks) and is symptomatic and icteric in only one third of patients. Serum aminotransferase levels generally increase greater than 10-fold elevated and as symptoms and signs resolve decrease into the normal range. Antibody to HCV is usually but not always present at the time of onset of symptoms. HCV RNA appears in the serum early during the incubation period, increases in titer and peaks at the time of symptoms, and then disappears in resolving disease. Importantly, 85% of patients with acute HCV infection develop chronic infection. In these patients, HCV RNA remains present and in approximately two thirds of patients, aminotransferases remain elevated in the range of 1.5- to 10-fold the upper limit of normal. The course of chronic hepatitis C is variable. Probably fewer than 20% of patients have symptoms and they are usually intermittent, vague, and nonspecific, largely being malaise and easy fatiguability. A small percentage of patients develop extrahepatic manifestations of hepatitis C, including cryoglobulinemia and glomerulonephritis. It is estimated that 20% to 30% of patients with chronic hepatitis C develop cirrhosis, but the process is generally slow and insidious. Once cirrhosis develops, symptoms are more common and the signs of end-stage liver disease can appear with jaundice, weakness, wasting, and gastrointestinal bleeding. Patients with cirrhosis are also at risk for developing hepatocellular carcinoma. Thus, this important liver disease has protean manifestations but is often insidious and can lead to end-stage liver disease despite the presence of few symptoms and signs of illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“HCV RNA can be detected in blood within 1–3 weeks after exposure.”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1361]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M. A., Hoofnagle, J. H., Manns, M. P., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,591
Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212202 · Cited by 1,658
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,191
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G. G., & Williams, R. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341302 · Cited by 963
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 870
Houghton, M., Weiner, A. J., Han, J. H., Kuo, G. C., & Choo, Q. (1991) · Hepatology · doi:10.1002/hep.1840140227 · Cited by 862
Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G. M., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 703
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell‐Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 668
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Ninno, E. D., Dioguardi, N., Kuo, G. C., Donato, M. F., Tommasini, M., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Conry‐Cantilena, C., VanRaden, M. J., Gibble, J. W., Melpolder, J. C., Shakil, A. O., Viladomiu, L., Cheung, L., DIBISCEGLIE, A., Hoofnagle, J. H., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627
Alter, M. J. (1990) · JAMA · doi:10.1001/jama.1990.03450170079026 · Cited by 611
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., INOUE, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 597
Fulminant hepatic failure: Summary of a workshop
Hoofnagle, J. H., Carithers, R. L., Shapiro, C. A., & Ascher, N. L. (1995) · Hepatology · doi:10.1002/hep.1840210137 · Cited by 578
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
Farci, P., Alter, H. J., Wong, D., Miller, R. H., Shih, J. W., Jett, B., & Purcell, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250205 · Cited by 571
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
Bisceglie, A. M. D., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 538
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
Alberti, A., Morsica, G., Chemello, L., Cavalletto, D., Noventa, F., Pontisso, P., & Ruol, A. (1992) · The Lancet · doi:10.1016/0140-6736(92)92234-7 · Cited by 380
Ribavirin as Therapy for Chronic Hepatitis C
Bisceglie, A. M. D., Conjeevaram, H. S., Fried, M. W., Sallie, R., Park, Y., Yurdaydın, C., Swain, M. G., Kleiner, D. E., Mahaney, K., & Hoofnagle, J. H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-12-199512150-00001 · Cited by 325
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
Alter, M. J., & Mast, E. E. (1994) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00146-1 · Cited by 320
Koziel, M. J., Dudley, D. D., Afdhal, N. H., Choo, Q. L., Houghton, M., Ralston, R., & Walker, B. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7522-7532.1993 · Cited by 286
Shakil, A., Conry‐Cantilena, C., Alter, H. J., Hayashi, P. H., Kleiner, D. E., Tedeschi, V., Krawczyński, K., Conjeevaram, H. S., Sallie, R., Bisceglie, A. M. D., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-5-199509010-00002 · Cited by 254
Silini, E. M., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 251
The natural course of chronic hepatitis C
Iwarson, S. A. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
Persistent Hepatitis C viremia after acute self-limiting posttransfusion Hepatitis C
Barrera, J. M., Bruguera, M., Ercilla, G., Gil, C., Celis, R., Gil, M. P., Onorato, V. M. D., Rodés, J., & Ordinas, A. (1995) · Hepatology · doi:10.1002/hep.1840210306 · Cited by 186
Baker, A. T. (1993) · Hepatology · doi:10.1016/0270-9139(93)90374-v · Cited by 160
Naito, M., Hayashi, N., Hagiwara, H., Hiramatsu, N., Kasahara, A., Fusamoto, H., & Kamada, T. (1994) · Hepatology · doi:10.1002/hep.1840190411 · Cited by 160
Relationship of aminotransferases to liver histological status in chronic hepatitis C.
Haber, M. M., Ab, W., Ad, H., & Reuben, A. (1995) · PubMed · Cited by 149
Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda
Decastro, M., Sánchez, J., Herrera, J. F., Cháves, A., Durán, R., Buey, L. G., García‐Monzón, C., Sequí, J., & Moreno‐Otero, R. (1993) · Hepatology · doi:10.1002/hep.1840170405 · Cited by 148
Liver transplantation for hepatitis C virus-related cirrhosis
Ascher, N. L., Lake, J. R., Emond, J. C., & Roberts, J. P. (1994) · Hepatology · doi:10.1002/hep.1840200708 · Cited by 138
Alter, M. J. (1990) · JAMA · doi:10.1001/jama.264.17.2231 · Cited by 122
Prieto, M., Olaso, V., Verdú, C., Córdoba, J., Gisbert, C., Rayón, M., Carrasco, D., Berenguer, M., Higón, M. D., & Berenguer, J. (1995) · Hepatology · doi:10.1002/hep.1840220207 · Cited by 116
McCormick, S. E., Goodman, Z., Maydonovitch, C. L., & Sjögren, M. H. (1996) · PubMed · Cited by 110
Mattsson, L., Sönnerborg, A. B., & Weiland, O. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00644.x · Cited by 108
Healey, C. J., CHAPMAN, R. W. G., & Fleming, K. A. (1995) · Gut · doi:10.1136/gut.37.2.274 · Cited by 108
Shindo, M. (1995) · Hepatology · doi:10.1016/0270-9139(95)90560-x · Cited by 100
Puoti, M., Zonaro, A., Ravaggi, A., Marin, M. G., Castelnuovo, F., & Cariani, E. (1992) · Hepatology · doi:10.1002/hep.1840160404 · Cited by 98
Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA
Alter, H. J., Sánchez-Pescador, R., Urdea, M. S., Wilber, J. C., LAGIER, R. J., Bisceglie, A. M. D., Shih, J. W., & Neuwald, P. (1995) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1995.tb00017.x · Cited by 93
Liver transplantation for chronic viral hepatitis
Wright, T. L., & Pereira, B. J. G. (1995) · Liver Transplantation and Surgery · doi:10.1002/lt.500010108 · Cited by 62
Hepatitis C virus infection and cryoglobulinemia
Lunel, F., & Musset, L. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80270-5 · Cited by 53
Merican, I., Sherlock, S., McIntyre, N., & Dusheiko, G. M. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068772 · Cited by 49
Serfaty, L., Nousbaum, J. B., Elghouzzi, M. H., Giral, P., Legendre, C., & Poupon, R. Y. (1995) · Hepatology · doi:10.1002/hep.1840210319 · Cited by 42
Histological evolution of chronic hepatitis C. Factors related to progression
Vaquer, P., Canet, R., Llompart, A., Riera, J., Obrador, A., & Gayà, J. (1994) · Liver International · doi:10.1111/j.1600-0676.1994.tb00086.x · Cited by 41
Clinical course of acute hepatitis C and changes in HCV markers
Hino, K., Sainokami, S., Shimoda, K., Niwa, H., & Iino, S. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02090055 · Cited by 41
Mclindon, J., Paver, W. K., Babbs, C., Yates, A. D., McMahon, R. F., Love, E. M., Craske, J., Christopher, J., & Warnes, T. W. (1995) · Journal of Infection · doi:10.1016/s0163-4453(95)90854-4 · Cited by 30
Cahen, D. L., van Leeuwen, D. J., ten Kate, F. J. W., Blok, A. P. R., Ousting, J., & Chamuleau, R. A. F. M. (1996) · Liver International · doi:10.1111/j.1600-0676.1996.tb00713.x · Cited by 25
Histological findings in asymptomatic hepatitis C virus carriers
Kodama, T., Tamaki, T., Katabami, S., KATAMUMA, A., Yamashita, K., Azuma, N., Kamijo, K., Kinoshita, H., & Yachi, A. (1993) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1993.tb01537.x · Cited by 21
Liver Histology in Anti-HCV-Positive Persons with Normal or Minimally Elevated Aminotransferases
Morales, T. G., Sampliner, R. E., Bhattacharyya, A., & Alter, M. J. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199512000-00011 · Cited by 14
The histopathological features of asymptomatic hepatitis C virus‐antibody positive blood donors
McMahon, R. F., YATES, A. J., Mclindon, J., Babbs, C., Love, E. M., & Warnes, T. W. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb00018.x · Cited by 9
Biochemical scores could reflect histological activity in chronic hepatitis C.
Testa, R., Picciotto, A., Lapertosa, G., Caglieris, S., Risso, D., Borzone, S., Campo, N., Alvarez, S., Varagona, G., & Pb, L. (1994) · PubMed · Cited by 2
Flagged first, then by citations
Research works printed but not linked: 6
- Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-1500.
- Barrera JM, Bruguera M, Guadalupe-Ercilla M, Gil C, Celis R, Gil MP, del Valle Onorato M, et al. Persistent hepatitis C viremia after acute HEPATOLOGY 1995;21:725-729.
- Morales TG, Sampliner RE, Bhattacharyya A, Alter MJ. Liver histology self-limiting posttransfusion hepatitis C. HEPATOLOGY 1995;21:639-644.
- Alter MJ, Hadler SC, Judson FN, Mares A, Alexander J, Hu PY, Miller in anti-HCV positive persons with normal or minimally elevated amino- transferases. J Clin Gastroenterol 1995;21:301-305.
- Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH. A non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
- Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Don- 1995;123:897-903.
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,059
Approved Antiviral Drugs over the Past 50 Years
Clercq, E. D., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,477
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,353
Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., Abu-Raddad, L. J., Assadi, R., Bhala, N. B., Cowie, B., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30579-7 · Cited by 1,350
Metadata
- Authors
- Hoofnagle, J. H.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Hoofnagle, J H
- Venue
- Hepatology
- Published
- 1997-12
- Volume
- 26
- Issue
- Supplement 3
- Pages
- 15S-20S
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1979931682
- Cited by
- 765
- References
- 47
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 11 · 2023: 8 · 2022: 8 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 14 · 2017: 11 · 2016: 25 · 2015: 20 · 2014: 32 · 2013: 26 · 2012: 20
- FWCI
- 27.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- hepatitis C, hepatitis C virus, acute hepatitis C, chronic hepatitis C, end-stage liver disease, liver cirrhosis, hepatocellular carcinoma, extrahepatic manifestations, cryoglobulinemia, glomerulonephritis, aminotransferase elevation, HCV RNA, incubation period, clinical spectrum
- MeSH terms
- Acute Disease, Transaminases, Chronic Disease, Hepatitis C, Humans, Severity of Illness Index, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
